Currently, out of the existing stock ratings of James Mainwaring - 6 which are a Hold (85.71%), 1 which are a Buy (14.29%)

James Mainwaring

Work Performance Price Targets & Ratings Chart

Analyst James Mainwaring works at ATLANTIC EQUITIES and is covering the Healthcare sector with 14 price targets and ratings displayed on 3 stocks.

James Mainwaring's average stock forecast success ratio is 44.44% with an average time for price targets to be met of 84 days.

Most recent stock forecast was given on MDT, Medtronic plc at 01-Jun-2022.

Wall Street Analyst James Mainwaring

Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $10.44 (8.38%) receiving and performance score of 0.66.

Average potential price target upside

A Agilent Technologies ABT Abbott Laboratories MDT Medtronic plc

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

150

$38.18 (34.14%)

160

1 months 14 days ago

13/19 (68.42%)

$17.89 (18.34%)

229

Buy

150

$38.18 (34.14%)

125

1 months 14 days ago

6/7 (85.71%)

$14.64 (18.27%)

266

120

$8.18 (7.32%)

124

1 months 14 days ago

6/6 (100%)

$6.72 (16.45%)

357

Buy

146

$34.18 (30.57%)

185

1 months 14 days ago

5/7 (71.43%)

$18.5 (30.18%)

530

Buy

140

$28.18 (25.20%)

144

1 months 14 days ago

8/15 (53.33%)

$17.78 (16.02%)

112

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by James Mainwaring?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart